Literature DB >> 31123032

Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1.

Jérôme Razanamahery1,2, Eli L Diamond3, Fleur Cohen-Aubart1,2, Karl-Heinz Plate4, Giota Lourida5, Frederic Charlotte6, Zofia Hélias-Rodzewicz7,8, Gaurav Goyal9, Ronald S Go9, Ahmet Dogan10, Omar Abdel-Wahab10, Benjamin Durham10, Neval Ozkaya10, Zahir Amoura1,2, Jean-Francois Emile7,8, Julien Haroche11,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31123032      PMCID： PMC6939531          DOI： 10.3324/haematol.2019.216937

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

Authors:  Julien Haroche; Frédéric Charlotte; Laurent Arnaud; Andreas von Deimling; Zofia Hélias-Rodzewicz; Baptiste Hervier; Fleur Cohen-Aubart; David Launay; Annette Lesot; Karima Mokhtari; Danielle Canioni; Louise Galmiche; Christian Rose; Marc Schmalzing; Sandra Croockewit; Marianne Kambouchner; Marie-Christine Copin; Sylvie Fraitag; Felix Sahm; Nicole Brousse; Zahir Amoura; Jean Donadieu; Jean-François Emile
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

2.  Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.

Authors:  Sofia Garces; L Jeffrey Medeiros; Keyur P Patel; Shaoying Li; Sergio Pina-Oviedo; Jingyi Li; Juan C Garces; Joseph D Khoury; C Cameron Yin
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

3.  Rosai-Dorfman disease of the genito-urinary tract: analysis of six cases from the testis and kidney.

Authors:  Chung-Chieh Wang; Turki O Al-Hussain; Juan Serrano-Olmo; Jonathan I Epstein
Journal:  Histopathology       Date:  2014-10-30       Impact factor: 5.087

4.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 5.  Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Authors:  Jean-François Emile; Oussama Abla; Sylvie Fraitag; Annacarin Horne; Julien Haroche; Jean Donadieu; Luis Requena-Caballero; Michael B Jordan; Omar Abdel-Wahab; Carl E Allen; Frédéric Charlotte; Eli L Diamond; R Maarten Egeler; Alain Fischer; Juana Gil Herrera; Jan-Inge Henter; Filip Janku; Miriam Merad; Jennifer Picarsic; Carlos Rodriguez-Galindo; Barret J Rollins; Abdellatif Tazi; Robert Vassallo; Lawrence M Weiss
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

6.  Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.

Authors:  Fleur Cohen-Aubart; Jean-François Emile; Fabrice Carrat; Zofia Helias-Rodzewicz; Valérie Taly; Frédéric Charlotte; Philippe Cluzel; Jean Donadieu; Ahmed Idbaih; Stéphane Barete; Zahir Amoura; Julien Haroche
Journal:  Am J Hematol       Date:  2018-02-10       Impact factor: 10.047

Review 7.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

8.  Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases.

Authors:  J A Andriko; A Morrison; C H Colegial; B J Davis; R V Jones
Journal:  Mod Pathol       Date:  2001-03       Impact factor: 7.842

Review 9.  [Rosai-Dorfman disease: Diagnosis and therapeutic challenges].

Authors:  F Cohen Aubart; J Haroche; J-F Emile; F Charlotte; S Barete; N Schleinitz; J Donadieu; Z Amoura
Journal:  Rev Med Interne       Date:  2018-03-01       Impact factor: 0.728

10.  Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.

Authors:  Baptiste Hervier; Julien Haroche; Laurent Arnaud; Frédéric Charlotte; Jean Donadieu; Antoine Néel; François Lifermann; Carles Villabona; Bruno Graffin; Olivier Hermine; Aude Rigolet; Camille Roubille; Eric Hachulla; Thierry Carmoi; Maud Bézier; Véronique Meignin; Marie Conrad; Laurence Marie; Elise Kostrzewa; Jean-Marie Michot; Stéphane Barete; Valerie Taly; Karine Cury; Jean-François Emile; Zahir Amoura
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113
View more
  6 in total

Review 1.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

Review 2.  Erdheim-Chester Disease: a Concise Review.

Authors:  Matthias Papo; Jean-François Emile; Thiago Trovati Maciel; Pierre Bay; Alistair Baber; Olivier Hermine; Zahir Amoura; Julien Haroche
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

Review 3.  Histiocytosis.

Authors:  Jean-François Emile; Fleur Cohen-Aubart; Matthew Collin; Sylvie Fraitag; Ahmed Idbaih; Omar Abdel-Wahab; Barrett J Rollins; Jean Donadieu; Julien Haroche
Journal:  Lancet       Date:  2021-04-23       Impact factor: 202.731

Review 4.  Rosai-Dorfman disease. A legacy of Professor Rosai that is still not exploited completely.

Authors:  Claudio Doglioni
Journal:  Pathologica       Date:  2021-10

Review 5.  Discovery through clinical sequencing in oncology.

Authors:  Mark T A Donoghue; Alison M Schram; David M Hyman; Barry S Taylor
Journal:  Nat Cancer       Date:  2020-08-10

6.  Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.

Authors:  Jerome Razanamahery; Sebastien Humbert; Jean-Francois Emile; Fleur Cohen-Aubart; Jean Fontan; Philippe Maksud; Sylvain Audia; Julien Haroche
Journal:  Front Med (Lausanne)       Date:  2021-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.